Parse Biosciences today announced their commitment to support researchers from the Icahn School of Medicine at Mount Sinai in generating one of the largest single cell datasets focused on ...

When Mindy Uhrlaub got tested to see if she was a carrier of the fatal mutation that causes the amyotrophic lateral sclerosis (ALS) her mom had, her neurogeneticist at Stanford told her that if she ...

Neurizon Therapeutics has developed a liquid version of its ALS treatment drug with the goal of improving the patient ...

Misplaced car keys, forgotten names and other lapses in memory are a normal part of life, especially as you age. However, ...

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic ...

Clinicians surveyed note the benefits of palliative care for people with ALS, along with barriers to its integration into ...